ReShape Lifesciences Inc. (RSLS)の価格はいくらですか

ReShape Lifesciences Inc. (RSLS)の価格は$3.92です

ReShape Lifesciences Inc. (RSLS)の時価総額は何ですか

ReShape Lifesciences Inc. (RSLS)の時価総額は$2.34Mです

ReShape Lifesciences Inc. (RSLS) の収益

Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy. Under development is the ReShape Vest system, an investigational, minimally invasive device that is laparoscopically implanted around the stomach to assist obese and morbidly obese patients in losing weight, without cutting or permanently removing parts of the stomach or bypassing any section of the gastrointestinal tract. ReShape also supports patients through the ReShapeCare virtual health coaching program, a telehealth service aimed at promoting healthy lifestyle adjustments for individuals undergoing medically supervised weight management. Additionally, the company is conducting preclinical development for ReShape Diabetes Bloc-Stim Neuromodulation, a technology intended for the treatment of type 2 diabetes mellitus. Among its offerings is the Obalon Balloon System, a swallowable capsule used to monitor and display the balloon's exact position during its placement. The company, initially incorporated as EnteroMedics Inc., changed its name to ReShape Lifesciences Inc. in 2017.

年	収益	変化
提供された日付のデータは十分ではありません。

年

収益

変化

提供された日付のデータは十分ではありません。

企業	収益	収益の差	国
Abbott Laboratories ABT.US	$46.59B	-	US
Stryker Corporation SYK.US	$25.84B	-	US
Medtronic plc MDT.US	$35.48B	-	IE
Boston Scientific Corporation BSX.US	$21.00B	-	US
Edwards Lifesciences Corporation EW.US	$6.51B	-	US

企業

収益

収益の差

国